The essence of the statin controversy is contained in the horizontally opposed views of the statin supporters and the critics of statin use. At present, in the UK, it is estimated that 7 million members of the public are taking statins. In the book the author notes that the statin supporters call for an even higher level of statin use claiming that many lives will be lost and much suffering will result if statin use is not maintained and expanded. The statin critics however claim equally that there is little to be gained and a strong prospect of serious damage to the health of a generation of statin users if this “medication of society” is continued in the present fashion. In Part 1 of the book, the author sets out the results oftaking statins which are claimed by the pharmaceutical companies and the organs of health care and shows, that by their own reckoning, the number of lives saved or as more accurately put, deaths delayed, is less than 1 for every 100 people treated over a period of 5 years. Even for this tiny number he provides evidence from third party medical scientists that the deaths are delayed on average for about 1 week after 5 years of treatment. With respect to adverse side effects, he provides references to independent studies which suggest that the number and seriousness of these effects is much greater than the level admitted by the statin supporters. Part 2 of the book provides information about various aspects of cardiovascular disease including the role of cholesterol and the functioning of statins in the human body which explains why the critics of statin use believe that the drug may lead to deterioration in health of the elderly and premature aging. Recognising that the statin lobby simply ignores the work of the statin critics, the author proposes an open review of patients which is overseen by a trustworthy body, independent of the pharmaceutical industry, the NHS and other organs of health care provision, all of which, he claims have an overwhelming financial vested interest in the outcome of such a review. He points out that an independent review of statins was called for by the Chief Medical Officer of the Government (Professor Dame Sally Davies) in 2015 and she was also asked for a review in 2016 by the Editor in chief of the British Medical Journal Fiona Godlee. A report by the Academy of Medical Sciences in response to the CMOs request was produced in 2017. It found, amongst other things, that a majority of members of the public would rather consult their relatives or friends than their doctor when considering whether to take a medication and in a survey a majority of doctors and members of the public believed that pharmaceutical companies manipulate the results of clinical trials to make their products look better. In order to press for a study the author has sent a copy of his book to every MP in the House of Commons with a covering letter urging them to establish the called for retrospective study of statin users and non-users. He argues that a truly independent study can only be ordered by the members of Parliament from both sides of the house on this non-party political issue. In order to put pressure on parliament to initiate an appropriate study, the author has established a website at www.thestatincontroversy.com on which members of the public, who have learned of the issue from the book or from the website can send an email to their MP urging the adoption of the authors proposal. There is also a section where MPs can comment on or question the subject of the book. About the author Although the author is not a medically trained doctor he is a scientist trained in the principles of scientific analysis with a Bachelor’s degree in Applied Physics and a Master’s degree in Operational research. He has used his skills to look into the subject of cardiovascular disease and present the two sides of the argument in a lucid exposition that can be easily read and understood by the layman. He is also a successful entrepreneur with significant achievements in the field of contact lens manufacture, where his company won the Queen’s Award for Industry and in the field of aviation where an aircraft developed by another of his companies flew at the Farnborough Airshow. In addition he has been involved in research projects in the field of cancer treatment and non-invasive measurement of cardiovascular disease. ‘The Statin Controversy: and how to resolve it’ is available now: https://amzn.to/2Jb1RBD. It will shortly be available as an ebook. All interested parties are urged to visit the author’s website, which contains a wealth of information on the issue at hand, as well as details for emailing any MP in the country to show support for the campaign: https://www.thestatincontroversy.com.

The essence of the statin controversy is contained in the horizontally opposed views of the statin supporters and the critics of statin use. At present, in the UK, it is estimated that 7 million members of the public are taking statins. In the book the author notes that the statin supporters call for an even higher level of statin use claiming that many lives will be lost and much suffering will result if statin use is not maintained and expanded. The statin critics however claim equally that there is little to be gained and a strong prospect of serious damage to the health of a generation of statin users if this “medication of society” is continued in the present fashion.

http://brn.firetrench.com

http://bsd.firetrench.com

http://nthn.firetrench.com

In Part 1 of the book, the author sets out the results oftaking statins which are claimed by the pharmaceutical companies and the organs of health care and shows, that by their own reckoning, the number of lives saved or as more accurately put, deaths delayed, is less than 1 for every 100 people treated over a period of 5 years. Even for this tiny number he provides evidence from third party medical scientists that the deaths are delayed on average for about 1 week after 5 years of treatment.  With respect to adverse side effects, he provides references to independent studies which suggest that the number and seriousness of these effects is much greater than the level admitted by the statin supporters.

Part 2 of the book provides information about various aspects of cardiovascular disease including the role of cholesterol and the functioning of statins in the human body which explains why the critics of statin use believe that the drug may lead to deterioration in health of the elderly and premature aging.

Recognising that the statin lobby simply ignores the work of the statin critics, the author proposes an open review of patients which is overseen by a trustworthy body, independent of the pharmaceutical industry, the NHS and other organs of health care provision, all of which, he claims have an overwhelming financial vested interest in the outcome of such a review. He points out that an independent review of statins was called for by the Chief Medical Officer of the Government (Professor Dame Sally Davies) in 2015 and she was also asked for a review in 2016 by the Editor in chief of the British Medical Journal Fiona Godlee. A report by the Academy of Medical Sciences in response to the CMOs request was produced in 2017. It found, amongst other things, that a majority of members of the public would rather consult their relatives or friends than their doctor when considering whether to take a medication and in a survey a majority of doctors and members of the public believed that pharmaceutical companies manipulate the results of clinical trials to make their products look better.

In order to press for a study the author has sent a copy of his book to every MP in the House of Commons with a covering letter urging them to establish the called for retrospective study of statin users and non-users. He argues that a truly independent study can only be ordered by the members of Parliament from both sides of the house on this non-party political issue.

In order to put pressure on parliament to initiate an appropriate study, the author has established a website at www.thestatincontroversy.com on which members of the public, who have learned of the issue from the book or from the website can send an email to their MP urging the adoption of the authors proposal. There is also a section where MPs can comment on or question the subject of the book.

 

About the author

Although the author is not a medically trained doctor he is a scientist trained in the principles of scientific analysis with a Bachelor’s degree in Applied Physics and a Master’s degree in Operational research. He has used his skills to look into the subject of cardiovascular disease and present the two sides of the argument in a lucid exposition that can be easily read and understood by the layman. He is also a successful entrepreneur with significant achievements in the field of contact lens manufacture, where his company won the Queen’s Award for Industry and in the field of aviation where an aircraft developed by another of his companies flew at the Farnborough Airshow. In addition he has been involved in research projects in the field of cancer treatment and non-invasive measurement of cardiovascular disease.

‘The Statin Controversy: and how to resolve it’ is available now: https://amzn.to/2Jb1RBD. It will shortly be available as an ebook.

All interested parties are urged to visit the author’s website, which contains a wealth of information on the issue at hand, as well as details for emailing any MP in the country to show support for the campaign: https://www.thestatincontroversy.com.